Clinical Studies
Learn more about studies on gastrointestinal, urinary, liver, behaviour and skin health in dogs and cats.
Protexin Veterinary is committed to a programme of continuous research and development, and has commissioned independent research that has been central to the growing scientific awareness that probiotics can make an effective contribution to good health.
The studies presented here explore the efficacy and relevance of several of our products designed to aid in the management of gastrointestinal, urinary, liver, skin diseases and behaviour in dogs and cats.

DermalEase: Topical treatment with sphingolipids and glycosaminoglycans for canine atopic dermatitis

Measurement of the S-adenosyl methionine (SAMe) content in a range of commercial veterinary SAMe supplements

Denamarin: Prospective randomized clinical trial assessing the efficacy of Denamarin for prevention of CCNU-induced hepatopathy in tumor-bearing dogs

Gut-Brain Axis Impact on Canine Anxiety Disorders: New Challenges for Behavioural Veterinary Medicine

Effects of oral administration of N-acetyl-d-glucosamine on plasma and urine concentrations of glycosaminoglycans in cats with idiopathic cystitis

Effect of dietary intake of L-Tryptophan supplementation on multi-housed cats presenting stress related behaviours

Cobalaplex/ Cobalazorb: Efficacy and tolerance of oral versus parenteral cyanocobalamin supplement in hypocobalaminaemic dogs with chronic enteropathy

Pro-Kolin Enterogenic: Effects of concurrent ronidazole and probiotic therapy in cats with tritrichomonas foetus-associated diarrhoea

Synbiotic DC: Efficacy of a probiotic-prebiotic supplement on incidence of diarrhoea in a dog shelter
